Welcome to the third differentiated service delivery (DSD) newsletter of 2025 from IAS – the International AIDS Society. This edition spotlights the latest DSD discussions and science presented at IAS 2025, the 13th IAS Conference on HIV Science.
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

View in browser

Welcome to the third differentiated service delivery (DSD) newsletter of 2025 from IAS – the International AIDS Society. This edition spotlights the latest DSD discussions and science presented at IAS 2025, the 13th IAS Conference on HIV Science.

DSD

Reflections on IAS 2025 from a DSD perspective

By Emmah Owidi, Partners in Health Research and Development, Center for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya


The science presented at IAS 2025 underscored the central role of DSD in achieving more person-centred, efficient and sustainable HIV programmes.


A major takeaway was that DSD presents a timely opportunity to sustain HIV service delivery while promoting health system resilience in the rapidly changing global funding environment. Discussions emphasized that tailoring services to client needs – whether for people living with HIV, key populations or people seeking HIV prevention – should now be the default.


The IAS-organized satellite, “Building forward: Differentiated service delivery as a catalyst for sustained and integrated HIV services amid funding uncertainty”, underscored the urgency for governments to embed DSD principles into national programmes and guidelines, and scale them up across communities in response to declining donor support.


Sessions also focused on expanding PrEP choice through implementing and scaling up new long-acting prevention tools and adapting DSD strategies for priority populations. Innovative community-led approaches showed promise in promoting equity by reaching populations often missed by traditional clinic-based services.


Artificial intelligence and other digital health technologies, such as mobile platforms for appointment reminders, digital TB diagnostics and adherence monitoring, and online PrEP delivery, were further showcased as essential for supporting self-care, service continuation and quality, and medication adherence.


The message from IAS 2025 is clear: DSD is a key pillar of healthcare that prioritizes choice, convenience and quality for clients while maximizing health system efficiency. The current challenge is to accelerate implementation, close equity gaps and ensure that every person benefits from truly differentiated, person-centred care.

Read the full piece

 

Don't miss

Download the IAS 2025 DSD slide deck and discover the latest DSD science.

Explore the new supplement of the Journal of the International AIDS Society (JIAS), “Differentiated service delivery – beyond HIV treatment for integration and other health needs”.

 

Get involved: Send your feedback on the TIER tool

“The TIER Tool – Tool for Intervention, Evaluation and Ranking”


The TIER Excel tool, developed by the IAS, is designed to support countries in their planning and prioritization of HIV programme elements in the context of funding shifts, providing a structured framework to prioritize HIV programme components.


We welcome feedback about the TIER tool at dsd@iasociety.org.

 

Looking ahead, looking back

Looking ahead …

  • The CQUIN annual meeting, taking place in Durban, South Africa, on 17-21 November, will convene representatives from network countries and global stakeholders to share progress in planning and implementation, performance updates, innovations, impact and challenges in service adaptations and system modifications.
  • The International Conference on AIDS and STIs in Africa (ICASA) will take place in Accra, Ghana, on 3-8 December 2025. Join the IAS DSD team for two satellite sessions on 3 December, focusing on prioritization of HIV services amid funding cuts and DSD for family planning.


Looking back …

  • The 12th South African AIDS Conference (SA AIDS) took place in Gauteng, South Africa, with the theme, Unite for Change – Empower Communities and Redefine Priorities for HIV/AIDS. Read more about the conference’s plenary discussion on the state of the South African HIV response.
  • Access content from the two satellite sessions organized by the IAS DSD programme at IAS 2025.
  • The World Health Organization (WHO) released its updated guidelines on HIV service delivery, recommending integrating services for hypertension, diabetes and mental health (including depression, anxiety and substance use) into HIV service delivery. It also provides updated recommendations on adherence support interventions shown to improve viral suppression and other health outcomes.
  • WHO launched guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis (PrEP). The guidelines recommend offering long-acting injectable lenacapavir as an additional HIV prevention choice as part of combination HIV prevention approaches.
  • The “UN80 Initiative” was published, stating: “We plan to sunset UNAIDS by the end of 2026. This would entail mainstreaming capacity and expertise into relevant entities of the UN development system in 2027.” UNAIDS has released a statement on this matter.
  • The US Department of State, Gilead Sciences and the Global Fund announced a partnership to scale up access to lenacapavir.
  • The Global Fund released its “Results Report 2025”, which shows increased access to HIV treatment.
  • The Gates Foundation announced a new partnership with Indian manufacturer Hetero Labs to expand access to generic versions of lenacapavir at USD 40 per client per year. In parallel, Unitaid, the Clinton Health Access Initiative and Wits RHI announced an agreement with Indian manufacturer Dr. Reddy’s Laboratories Ltd. to make lenacapavir available in 120 low- and middle-income countries, starting in 2027.
  • The US Department of State released the “America First Global Health Strategy”. Read analyses of the strategy here and here.

 

What we're reading

Evaluating the impact of differentiated service delivery (DSD) on retention in care and HIV viral suppression in South Africa: A target trial emulation using routine healthcare data, Huber AN et al, PLoS Med, August 2025


This study compared HIV treatment outcomes for a large cohort of clients in South Africa enrolled in DSD models with those eligible but not enrolled. Using a target trial emulation approach, it assessed retention in care and viral suppression over 12, 24 and 36 months. DSD enrolment was associated with slightly higher retention and similar viral suppression compared with non-DSD clients. The findings suggest that DSD models maintain clinical effectiveness while offering non-clinical benefits, such as saving provider and client time.

Cost and effectiveness of differentiated ART service delivery strategies in Zambia: a modelling analysis using routine data, Lekodeba NA et al, J Int AIDS Soc, July 2025

 

This study used a mathematical modelling approach to evaluate the cost effectiveness of different DSD models for HIV treatment in Zambia. Using retention and viral suppression data from a national client cohort between 2018 and 2022, the analysis compared 125 scenarios of nine DSD models. Six scenarios were assessed as cost effective, with 6MMD-only being cost saving, improving retention and viral suppression while lowering client costs. The authors suggest that nationwide scale up of 6MMD to all eligible clients is likely cost saving, with further health gains possible through tailored combinations of other DSD models for specific sub-populations.

Seizing the moment: the potential of PrEP choice and innovation to transform HIV prevention, Schmidt HA et al, J Int AIDS Soc, July 2025


This commentary highlights how expanding PrEP options and service delivery innovations could strengthen global HIV prevention. While limited rollout of oral PrEP and challenges with PrEP persistence restrict its impact, long-acting injectables have the potential to overcome these challenges. Providing PrEP choices through DSD models can improve access, uptake and client satisfaction. However, overcoming programmatic challenges, including costs, monitoring and policy support, will be critical to fully realizing the potential of PrEP.

Home-Based Care for Hypertension in Rural South Africa, Siedner MJ et al, N Engl J Med, Epub ahead of print, Sept 2025


This randomized controlled trial in South Africa tested home-based hypertension care led by community health workers (CHWs) against standard clinic-based care. At six months, both CHW-led models significantly reduced systolic blood pressure compared with standard care, with the enhanced CHW group achieving the greatest improvements. Hypertension control rates were also substantially higher in both CHW groups, and benefits persisted at 12 months. Findings suggest that home-based care is an effective strategy for improving hypertension management.


Effectiveness and experiences with differentiated service delivery of HIV care in Kisumu County, Kenya: A mixed methods study, 2014–2021, Odhiambo F et al, PLOS Glob Public Health, August 2025


This mixed-methods study evaluated the impact of DSD models for HIV care in Kisumu County, Kenya, following WHO’s 2015 test and treat policy. A pre-post analysis of clinically “stable” adult clients showed significant improvements in retention, increasing from 86.4% pre-DSD to over 98% at 12 and 24 months, with sustained viral suppression. Focus group discussions indicated high satisfaction among both clients and healthcare workers, citing greater efficiency, improved staff attitudes and reduced clinic workload. Many clients preferred facility-based DSD models over community-based options due to concerns about stigma and privacy.

“If your CD4 count lowers, that is when you are similar to a person that is non-existent” A qualitative exploration of perceptions around advanced HIV disease in South Africa, Pita TP et al, BMC Public Health, July 2025


This qualitative study explored perceptions and influencing factors of advanced HIV disease (AHD) in South Africa. Interviews and focus group discussions with people living with HIV, nurses and policy makers indicated that most clients were unfamiliar with the term, AHD, and often confused CD4 counts with viral load testing. Key contributors to AHD included poor adherence, clinic avoidance, structural barriers to care, mental health challenges, reliance on traditional medicine and stigma. The findings underscore the need for improved community education, better integration of mental health support and re-engagement strategies.

A research framework to support re-engagement and continuous engagement in HIV care, Lavoie MC et al, Lancet HIV, Sept 2025


This viewpoint argues that disengagement from HIV care is a critical weakness in the HIV response, and calls for clearer distinctions between concepts such as loss to follow up and unknown care status, and for flexible data harmonization to generate stronger, comparable evidence across studies. The authors emphasize that effective re-engagement requires not just tracing clients, but also addressing systemic barriers, adopting client-centred models and testing interventions tailored to diverse populations. They conclude that a global research agenda, supported by methodological guidance, is needed to advance sustainable strategies for continuous engagement and re-engagement in HIV care.

 

What we're watching

Voices from the 12th South African AIDS Conference


Watch this video sharing perspectives on the South African HIV response from community activists, researchers and policy makers at the 12th South African AIDS Conference.

 

Get in touch

Do you have content for the next newsletter? We want to hear from you.
Email us at dsd@iasociety.org.


www.differentiatedservicedelivery.org

 

IAS logo

Photo credits in order of appearance: 
(1-2) IAS


© 2025 International AIDS Society. All rights reserved.

Av. De France 23, 1202 Geneve, Switzerland

Unsubscribe